Monoclonal Antibodies in the News
- 36 people with long COVID tested a potential treatment. Here’s what the study found - San Francisco Chronicle
- Monoclonal Antibodies - American Medical Association
- New momentum for monoclonal antibodies manufacturing in Africa - IAVI
- NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma - Pharmacy Times
- Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus - Nature
©
2025
MAb Technologies | monoclonal antibodies to transporter proteins
Website by 3by400, North Georgia web design team using Joomla!
Website by 3by400, North Georgia web design team using Joomla!